| Market Cap | 10.59B | P/E | 11.64 | EPS this Y | - | Ern Qtrly Grth | -38.20% |
| Income | 2.01B | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | 40.69B | PEG | - | EPS past 5Y | - | 200D Avg Chg | -9.00% |
| Dividend | 16.00% | Price/Book | 0.16 | EPS next 5Y | - | 52W High Chg | -25.00% |
| Recommedations | - | Quick Ratio | 0.71 | Shares Outstanding | 551.94M | 52W Low Chg | 20.00% |
| Insider Own | 14.13% | ROA | 0.61% | Shares Float | 1.70B | Beta | 0.67 |
| Inst Own | 21.34% | ROE | 4.56% | Shares Shorted/Prior | -/- | Price | 2.68 |
| Gross Margin | 47.16% | Profit Margin | 4.94% | Avg. Volume | 3,466 | Target Price | - |
| Oper. Margin | 9.65% | Earnings Date | Apr 29 | Volume | 21 | Change | 0.00% |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, anti-infection, API's and intermediate, metabolism, alimentary system, cardiovascular and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services, and investment management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.